Literature DB >> 11504371

An experience of stereotactic radiation therapy for primary intracranial choriocarcinoma.

S Kohyama1, M Uematsu, S Ishihara, K Shima, S Tamai, S Kusano.   

Abstract

We report on a patient with choriocarcinoma in the pineal region who was successfully treated with stereotactic radiation therapy (SRT). The increased level of serum human chorionic gonadotropin (HCG) was lowered during chemotherapy with etoposide, cisplatin, and ifosfamide. However, HCG was not normalized and magnetic resonance images still showed an enhanced tumor mass with gadolinium. The patient underwent SRT of 40 Gy at an 80% isodose line per 10 fractions over two weeks, followed by conventional craniospinal irradiation of 32.4 Gy. The level of HCG dropped below the detection limit. The patient has been in good condition for more than four years after the completion of treatment, without any signs of recurrence. We propose SRT as a valid treatment option for malignant germ cell tumors in the pineal region.

Entities:  

Mesh:

Year:  2001        PMID: 11504371     DOI: 10.1177/030089160108700310

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  4 in total

1.  Primary intracranial choriocarcinoma: MR imaging findings.

Authors:  X-F Lv; Y-W Qiu; X-L Zhang; L-J Han; S-J Qiu; W Xiong; G Wen; Y-Z Zhang; J Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-08       Impact factor: 3.825

Review 2.  Prognostic factors and therapeutic problems of primary intracranial choriocarcinoma/germ-cell tumors with high levels of HCG.

Authors:  Jun Shinoda; Noboru Sakai; Hirohito Yano; Tatsuaki Hattori; Akio Ohkuma; Heima Sakaguchi
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

Review 3.  Management of primary intracranial germ cell tumors.

Authors:  Athanassios P Kyritsis
Journal:  J Neurooncol       Date:  2009-07-09       Impact factor: 4.130

4.  Intracranial choriocarcinoma occurrence in males: Two cases and a review of the literature.

Authors:  Jianyi Guo; Chunlong Zhong; Qiang Liu; Jiwen Xu; Yan Zheng; Siyi Xu; Yang Gao; Yang Guo; Yong Wang; Qizhong Luo; Jiyao Jiang
Journal:  Oncol Lett       Date:  2013-09-09       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.